Clinical Trial Update: A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating PRT-201 administered after arteriovenous fistula creation in chronic kidney disease patients has completed; the update does not provide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• PRT-201

Snippet

Sponsor: Proteon Therapeutics | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED